Banking Recap

Eargo, Inc. to Be Acquired

This transaction is a take-private cash acquisition in which Patient Square Capital is acquiring Eargo, Inc., a healthcare sector company. The deal falls under the M&A product group, and the disclosed value is not stated in the source document.

Feb 16, 2024·SEC EDGAR (8-K)·pending regulatory·take-private cash acquisition

This summary is sourced from an SEC EDGAR Form 8-K filed and published on February 16, 2024.

On the financial advisory side, only one advisor is named: Perella Weinberg Partners LP acted as financial advisor to the special committee of Eargo's board, the target side, though no lead or non-lead designation is given for this role. No financial advisor is named for Patient Square Capital, the acquirer.

Legal counsel, by contrast, is more fully documented across three firms. Ropes & Gray LLP acted as legal counsel to Patient Square, the acquirer. On the target side, two firms are named: Davis Polk & Wardwell LLP acted as legal counsel to the special committee, alongside Perella Weinberg's financial advisory role for that same committee, while Freshfields Bruckhaus Deringer LLP acted as legal counsel to the company, Eargo itself, as distinct from the special committee.

The facts block confirms this is structured as a take-private cash acquisition, but provides no further detail on the per-share price, financing sources for Patient Square Capital, or any other structural terms of the transaction.

Several material facts are not disclosed. The transaction's dollar value is explicitly stated as not disclosed in the source document. No financial advisor is named for the acquirer, Patient Square Capital. No expected closing date is given, and no detail on the purchase price per share is provided beyond the general cash acquisition characterization.